Genus - Director/PDMR Shareholding

Genus

24/09/2025 11:35

RNS Number : 6557A

Genus PLC

24 September 2025

 

24 September 2025

 

Genus plc

 

Director/PDMR Shareholding

 

Genus plc (LSE: GNS) announces that on 24 September 2025 Mark Birri, Chief Corporate Development Officer, purchased 700 shares in an Individual Savings Account.

 

The below notification, made in accordance with Article 19 of the Market Abuse Regulation (EU) 596/2014 as it forms part of domestic law by virtue of the European Union (Withdrawal) Act 2018, gives further detail on the PDMR transaction described above.

 

For further information please contact:

 

Genus:

Vaughn Walton, Deputy Company Secretary                         Tel: +44 (0)1256 347100

 

 

 

1.
Details of the person discharging managerial responsibilities / person closely associated
a.
Name
Mark Birri
2.
Reason for the notification
a.
Position/status
Chief Corporate Development Officer
b.
Initial notification
/Amendment
Initial notification
3.
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a.
Name
Genus plc
b.
LEI
54930022EOITNKSIGH56
4.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a.
Description of the
Financial instrument, type of instrument
Identification code
Ordinary shares of 10p each
GB0002074580
b.
Nature of the transaction
Purchase of shares in an Individual Savings Account.
c.
Price(s) and volume(s)
Price(s)
Volume(s)
2350p
700
d.
Aggregated information
· Aggregated volume
· Price
Average price(s)
Total volume(s)
2350p
700
e.
Date of the transaction
2025-09-24
f.
Place of the transaction
London Stock Exchange, Main Market (XLON)

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

 
  END

 

 
DSHUSORRVOUKUAR